Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2004
12/02/2004US20040241807 Interleukin-1 related gene and protein
12/02/2004US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders
12/02/2004US20040241803 25 human secreted proteins
12/02/2004US20040241796 Kinase for use as tool in identification of modulators for treatment and prevention of diabetic, cell prolliferative, cardiovascular and respiratory system disorders
12/02/2004US20040241792 Substrates and assays for beta-secretase
12/02/2004US20040241791 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
12/02/2004US20040241789 Selectively deformable container end closure
12/02/2004US20040241787 Natural fibers has groove and cutting notch on surface, embedded with agar, for inoculating and cultivating microorganism in a medium, monitoring by a scanning electron microscope, promoting yeast growth and proliferation for food, sake brewing
12/02/2004US20040241786 Single tube screen
12/02/2004US20040241784 Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
12/02/2004US20040241783 Assay device and method for chemical or biological screening
12/02/2004US20040241782 Methods and means for detecting enzymatic cleavage and linkage reactions
12/02/2004US20040241780 Chemically modified mutant enzymes and methods for producing them, and screening them for amidase and /or esterase activity
12/02/2004US20040241779 comprises strip containing two pads positioned on adhesive backing for receiving samples; high speed; for analyzing glucose-6-phosphate dehydrogenase activity
12/02/2004US20040241775 Methods and kits for determining risk of pre-term delivery
12/02/2004US20040241771 Electrode compositions and configurations for electrochemical bioreactor systems
12/02/2004US20040241768 Quencher (Q), tethering element (T), and ligand (L); ligand binds biomolecule and separates from fluoropolymer (polyelectrolytes), creating detectable fluorescence; peptide nucleic acids; fluorescent dyes; bioassays; kits; solid phase synthesis
12/02/2004US20040241763 Detecting autoimmune and nervous system disfunction via ratio between glycans and immunoglobulin binding agent
12/02/2004US20040241761 Using human estrogen receptor gene expression as diagnostic indicator of diabetes; antidiabetic agents
12/02/2004US20040241760 Kinesin-like proteins and methods of use
12/02/2004US20040241759 Using encapsulated cells as diagnostic tools for detection of ligand binding proteins and rapid sorting of libraries derived from mixed population of organisms
12/02/2004US20040241756 Methods and means of histone methylation
12/02/2004US20040241755 Human cell assay to determine effect of sample compounds on Col2 enhancer expression
12/02/2004US20040241747 Nutrient broth comprising vancomycin, D-cycloserine and D-lactate for use in identifying and propagating vancomycin resistant gram positive microorganisms
12/02/2004US20040241746 Amperometric biosensor in thick film technology
12/02/2004US20040241742 Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same
12/02/2004US20040241740 Lafora's disease gene
12/02/2004US20040241738 Detection of binding reactions using labels detected by mediated catalytic electrochemistry
12/02/2004US20040241737 Methods for diagnosing mood disorders
12/02/2004US20040241735 Determining genomic constituency of preferential regions of chromosome via oligonucleotide binding and amplification; identifying regions of polymorphism in genomes
12/02/2004US20040241734 Methods for in situ hybridization without the need for competitior DNA
12/02/2004US20040241733 High throughput screening assay systems in microscale fluidic devices
12/02/2004US20040241732 Method of generating long nucleic acid molecules of defined sequence
12/02/2004US20040241731 Methods of producing nucleic acid ligands
12/02/2004US20040241730 Visualizing expression data on chromosomal graphic schemes
12/02/2004US20040241729 Method for the detection of Chagas disease related gene transcripts in blood
12/02/2004US20040241728 Using enhanced expression of lung marker expressed sequence tags to diagnose and prognose respiratory system disorders
12/02/2004US20040241727 Method for the detection of schizophrenia related gene transcripts in blood
12/02/2004US20040241726 Method for the detection of allergies related gene transcripts in blood
12/02/2004US20040241725 Lung cancer detection
12/02/2004US20040241724 Immobilization method and kit therefor
12/02/2004US20040241723 Identifying polymorphic sequences which are associated with an obesity gene and enhanced milk and milk protein production
12/02/2004US20040241722 Molecular haplotyping of genomic DNA
12/02/2004US20040241719 Nucleic acid sequence analysis
12/02/2004US20040241717 Oligomeric compounds for the modulation of thioredoxin expression
12/02/2004US20040241716 Terminal-phosphate-labeled nucleotides with new linkers
12/02/2004US20040241715 Genes identified as required for proliferation in escherichia coli
12/02/2004US20040241714 Methods of assessment of drug metabolizing enzymes
12/02/2004US20040241713 Composition for immobilization of biological macromolecules in hydrogels, a method for preparing a composition, a biochip, and a method for performing the PCR over biochip
12/02/2004US20040241712 Diagnostic detection of nucleic acids
12/02/2004US20040241711 a first specific binding pair (sbp) member capable of binding to the analyte or to a second sbp member to form a complex related to the presence of said analyte, sbp members is bound to a polymer, dispersed in a dopant activating chemiluminescent substance, determining effect of activation
12/02/2004US20040241710 Methods of detecting colorectal cancer
12/02/2004US20040241708 Plasmid for use as gene transfer tool in heterologous gene expression; bioreactors
12/02/2004US20040241707 Enhanced diagnostic potential of prostate-specific antigen expressing cells
12/02/2004US20040241706 Such as 2-amino-6-O-(2',2'-dimethyl)propyl-9-N-benzylpurine with modified guanosine triphosphate groups, which affects activity of mutant strains rather than wild-type strains; enzyme inhibitors; host cells; solid phase synthesis
12/02/2004US20040241705 Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi
12/02/2004US20040241704 Method for bisulfite treatment
12/02/2004US20040241699 Detection of polynucleotide hybridization
12/02/2004US20040241698 Extracting actinomycetes nucleotide sequences from soil and identifying biocatalytic nucleotide sequences; for use as tools in genetic engineering
12/02/2004US20040241697 Compositions and methods to identify haplotypes
12/02/2004US20040241696 Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids
12/02/2004US20040241694 Using expression patter of neurodegenerative marker to diagnose/prognose brain disorders
12/02/2004US20040241692 Correction method, apparatus and recording medium on oligonucleotide microarray using principal component analysis
12/02/2004US20040241690 Method of evaluating biocompatibility
12/02/2004US20040241685 Method of analyzing nucleic acid specifying gene showing change in expression dose in schizophrenia
12/02/2004US20040241684 Directed protein modification by iterative sequence insertion
12/02/2004US20040241682 Cancer
12/02/2004US20040241679 Amplifying target sequence in presence of duplex binding agent, polymerase and labeled primer/probe, recovering product and monitoring fluorescence; kits
12/02/2004US20040241678 Polynucleotide sequencing method
12/02/2004US20040241676 Using physical map of pig genome to identify mutants in mast/stem cell growth factor receptor (KIT) for use in determining coat color in swine
12/02/2004US20040241675 Method and device for determining and selecting molecule-molecule interactions
12/02/2004US20040241673 Non-cytotoxic pap mutants
12/02/2004US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines
12/02/2004US20040241670 Method and system for partitioning pixels in a scanned image of a microarray into a set of feature pixels and a set of background pixels
12/02/2004US20040241669 Using image analysis to identify regions of biopolymer hybridization or interaction along a microarray; genomics and gene expression analysis
12/02/2004US20040241668 Ligand array assays that include a low surface tension fluid wash step and compositions for practicing the same
12/02/2004US20040241666 Preserving immobilized ligand arrays using fixative laced propylene carbonate and detection of preferential biopolymer on solid substrate; genomics; proteomics
12/02/2004US20040241665 Preparing microarray using pulse-jet fluid deposition of mixture which comprises nucleoside monomer and weak tetrazole acid onto solid support; genomic analysis; bioparticle quantification
12/02/2004US20040241664 Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue
12/02/2004US20040241663 Preserving immobilized ligand arrays using fixative laced propylene carbonate; genomics; proteomics
12/02/2004US20040241662 Detecting microbial contamination in grain and related products
12/02/2004US20040241661 Using differential labeling and colorimetric analysis to determine concentration of analytes sample; bioassay for use in gene expression analysis, DNA sequencing, mutation detection, genomics and proteomics
12/02/2004US20040241658 Comparative genomic hybridiztion assays using immobilized oligonucleotide targets with initially small sample sizes and compositions for practicing the same
12/02/2004US20040241657 Nucleotide sequences which hybridizes to variant/allelic sequence in haplotype block for use in diagnosis and prognosis of hepatic and inflammatory disorders
12/02/2004US20040241655 Using multiple primers pairs concurrently to amplify and genomic sequences; genotyping; identifying restriction fragment and single nucleotide polymorphism; high throughput assay
12/02/2004US20040241654 Solid support for dry collection, transportation, and storage of specimens at temperatures ranging between 4 and 50 degrees C; screening and identifying gene sequences of pathogens
12/02/2004US20040241653 Methods for identifying marker genes for cancer
12/02/2004US20040241651 Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
12/02/2004US20040241650 Computer-directed assembly of a polynucleotide encoding a target polypeptide
12/02/2004US20040241649 Rna containing coenzymes, biotin, or fluorophores, and methods for their preparation and use
12/02/2004US20040241648 Phosphoribosyl pyrophosphate synthetase 1as herbicidal target
12/02/2004US20040241644 Isolating, icubating and assaying solid, semi-solid or liquid sample for presence of microorganism; screening food, water, wastewater and botanical products for pathogen contamination
12/02/2004US20040241643 Oligonucleotides for detecting infection of human blood; microarrays and disease diagnosis
12/02/2004US20040241640 Internalisation of virus into cells
12/02/2004US20040241637 Method for establishing a standardized detection system for identifying a microorganism
12/02/2004US20040241636 Characterizing gene/protein function using high throughput assays; elucidation of biosynthetic pathways
12/02/2004US20040241462 organic polymer linker material layer for enhancing the bond between a gold thin layer and a substrate; terminal end of polymer linker material is capable of reacting with substrate and the other end has positive charge capable of interaction with a negative charge of gold colloid
12/02/2004US20040241205 capsules comprising biocompatible silica sol-gel matrices that encapsulate chemical intermediates or prodrugs that convert when contacted with tissues and/or fluids; grafting encapsulated L-amino acid decarboxylase in the brain to convert L-dopa to dopamine for prophylaxis of Parkinson's disease
12/02/2004US20040241183 Human lymphocyte vaccine adjuvant
12/02/2004US20040241181 Preferentially inducing a more potent CD8+ T cell response to an immunogen by delivering a recombinant simian adenovirus comprising a nucleic acid molecule encoding an immunogen under the control of gene expression regulatory sequences directing expression of the immunogen; HIV; rabies; papilloma virus